RxDoctor Payments Data

Michael Rocco, MD

Nephrology · Winston Salem, NCNPI 1437134525

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $16,835 of the $20,900 with a category attached, or 80.6%. Baxter Healthcare accounts for 69.3% of it on its own, with 3 other manufacturers making up the rest. Among nephrology clinicians in NC with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$20,900in general payments, 2019–2025

Across 40 payments — averaging $522.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Baxter Healthcare$14K
  • Bayer$5K
  • Boehringer Ingelheim$923
  • Boehringer Ingelheim International GmbH$433
$639,020in research payments, 2019–2025

Across 143 payments — averaging $4468.67 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Boehringer Ingelheim International GmbH$279K
  • Boehringer Ingelheim Pharma GmbH & Co.kg$195K
  • Bayer$117K
  • GSK$26K
  • Astrazeneca UK Limited$22K

What the payments were for

  • Consulting fees$16,83581%
  • Travel & lodging$3,36116%
  • Food & beverage$7033%

General payments by program year

19
22

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$20,900 in reported general payments places this provider in the 90th percentile of 366 nephrology providers in North Carolina.

See all nephrology providers in North Carolina

Medicare billing

Part B allowed, 2024
$61,221
Medicare patients
176
Services billed
438

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Lanthanum Carbonate11$21,072
JardianceEmpagliflozin23$17,560
Sevelamer Carbonate55$6,705
LokelmaSodium Zirconium Cyclosilicate15$5,838
Calcium Acetate21$2,820
Labetalol Hcl14$922
Losartan Potassium67$728
Hydralazine Hcl60$599
Potassium Chloride14$590
Amlodipine Besylate91$507
Acyclovir14$434
Torsemide12$328
Lisinopril41$267
Prednisone42$259
Furosemide40$219

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance$923$17,56023 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 366 nephrology providers in North Carolina.

Other nephrology in Winston Salem

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →